Cargando…
Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease
Asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous airway diseases associated with significant morbidity and mortality. Pharmacological treatment is delivered primarily through the inhalation route using various devices. Optimal disease control is highly dependent upon patient...
Autores principales: | Shakshuki, Ayah, Agu, Remigius U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964260/ https://www.ncbi.nlm.nih.gov/pubmed/32026344 http://dx.doi.org/10.1007/s41030-017-0046-2 |
Ejemplares similares
-
Development of Intranasal Levothyroxine Powder Delivery for Hypothyroidism
por: Imran, Syed Ali, et al.
Publicado: (2021) -
Preliminary Studies on Validation of Calu-3 Cell Line as a Model for Screening Respiratory Mucosa Irritation and Toxicity
por: Ihekwereme, Chibueze, et al.
Publicado: (2014) -
Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives
por: Louhelainen, Noora, et al.
Publicado: (2008) -
Current trends in polymer microneedle for transdermal drug delivery
por: Ahmed Saeed AL-Japairai, Khater, et al.
Publicado: (2020) -
Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)